Search results
Results from the WOW.Com Content Network
The CDBG program was enacted in 1974 by President Gerald Ford through the Housing and Community Development Act of 1974 and took effect in January 1975. Most directly, the law was a response to the Nixon administration's 1973 funding moratorium on many Department of Housing and Urban Development (HUD) programs. [1]
The Office of Community Planning and Development is an agency within the United States Department of Housing and Urban Development (HUD). The office administers the grant programs that help communities plan and finance their growth and development, increase their capacity to govern, and provide shelter and services for homeless people.
The program is commonly referred to as the Home Investment or Home Partnership Program, and is often operating in conjunction with other housing and other urban development programs, such as the CDBG program. Its federal identification number, or CFDA number, is 14.239. [1]
To support community and housing needs for Sandy and other 2011–2013 eligible disasters, the amendment also provides added funding for the Community Development Block Grant program to assist state and local governments meet needs for public infrastructure like hospitals, utilities and roads, repairs for small businesses, rental assistance ...
Examples of this type of grant includes the Community Development Block Grant and the Alcohol, Drug Abuse, and Mental Health Services Block Grant. Recipients of block grants have more leeway in using funds than recipients of individual categorical grants. [citation needed] Earmark grants are explicitly specified in appropriations of the U.S ...
A mortgage point could cost 1% of your mortgage amount, which means about $5,000 on a $500,000 home loan, with each point lowering your interest rate by about 0.25%, depending on your lender and loan.
The theory notes, to consider with accountability for reasonableness is to consider the following four conditions: [4] Relevance: The decision-making criteria and factors considered should be relevant to the goals and values of the affected stakeholders, such as patients, healthcare providers, and the community.
Considering that it costs $10 billion to $15 billion to bring a new drug to market, it would be a lot more cost effective to repurpose an existing drug, Ditlev said, than to develop a new one.